Urogen Pharma Ltd
F:UR8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Urogen Pharma Ltd
F:UR8
|
IL |
|
E
|
Elan Corp
F:25E
|
JP |
|
C
|
CropEnergies AG
XMUN:CE2
|
DE |
|
C
|
China Eastern Airlines Corp Ltd
F:CIAH
|
CN |
|
H
|
Hellenic Telecommunications Organization SA
XBER:OTES
|
GR |
|
Rockcliff Metals Corp
F:RO0A
|
CA |
|
Concord Medical Services Holdings Ltd
NYSE:CCM
|
CN |
|
R
|
Restaurant Brands New Zealand Ltd
OTC:RTBRF
|
NZ |
Wall St Price Targets
UR8 Price Targets Summary
Urogen Pharma Ltd
According to Wall Street analysts, the average 1-year price target for UR8 is 19.58 EUR with a low forecast of 15.51 EUR and a high forecast of 25.19 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UR8's stock price target?
Price Target
19.58
EUR
According to Wall Street analysts, the average 1-year price target for UR8 is 19.58 EUR with a low forecast of 15.51 EUR and a high forecast of 25.19 EUR.
What is the Revenue forecast for Urogen Pharma Ltd?
Projected CAGR
31%
The compound annual growth rate for Revenue over the next 8 years is 31%.
What is the Gross Profit forecast for Urogen Pharma Ltd?
Projected CAGR
31%
The compound annual growth rate for Gross Profit over the next 8 years is 31%.
